You searched for "Ocular Surface"

25 results found

New cataract, cornea and ocular surface disease innovations from Kestrel Ophthalmics

Kestrel Ophthalmics, (a Cutting Edge company) is pleased to introduce an integrated medical and surgical approach to treat a range of conditions.

Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases

This is a retrospective study of patients with ocular surface inflammatory diseases (OSIDs) treated with IKERVIS in a single centre between 2016 to 2019 with at least six months follow-up. Clinical outcome was defined as successful (resolved or stable disease),...

Histopathology-guided management of ocular surface squamous neoplasia (OSSN) with corneal stromal or scleral invasion using ruthenium-106 plaque brachytherapy

This is a retrospective interventional consecutive case series of 42 eyes of 42 patients with OSSN with histopathologically proven corneal stromal and / or scleral invasion following excision biopsy. The mean tumour basal diameter was 9.3mm and thickness of 3.1mm...

The 4th Ocular Surface Masterclass

The world-class faculty for the 4th National Ocular Surface Masterclass include keynote Dart Lecture by Prof Graham Lee (Brisbane, Australia) on 25 years experience of Ocular Surface Squamous Neoplasia, and keynote Dua Lecture by Prof Ian Rennie on pigmented lesions...

RSM: Ocular surface surgery

A Lifestyle Epidemic: Ocular Surface Disease

The Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, has just completed its recent global Workshop, entitled “A Lifestyle Epidemic: Ocular Surface Disease.” These 8 presentations will be available to watch at any time during these 2 days. More details upon registration.

ECLSO (European Contact Lens and Ocular Surface) Congress 2022

This year ECLSO will be hosting their 49th scientific congress from the from 2-3 September in Paris. The society is affiliated to MCLOSA, the UK-based ocular surface society, and the European dry eye society EUDES, and aims to promote continuous...

OSI (Ocular Surface Insight) Annual Symposium & Dry Eye Masterclass

By popular demand Ocular Surface Insight (OSI) is running another 2-day conference in London on the 24-25 March 2023. This event gives ophthalmologists, optometrists and trainees the chance to hear from world-leading experts in ocular surface disease at this new...

Significant improvements in Ocular Surface Disease (OSD) in Glaucoma patients reported following implantation of iStent inject at the time of cataract surgery

A prospective study of patients undergoing trabecular micro-bypass implantation with iStent or iStent inject® at the time of cataract surgery shows clinically and statistically significant improvements in ocular surface disease (OSD), including tear break-up time, corneal/conjunctival staining, and Ocular Surface Disease Index scores (OSDI).